Recruiting
Phase 1

Effect of Moderate Renal Impairment and Race/Ethnicity on Treosulfan Pharmacokinetics

Sponsor:

medac GmbH

Code:

NCT05534620

Conditions

Acute Myeloid Leukaemia (AML)

Myelodysplastic Syndrome (MDS)

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Treosulfan

Fludarabine

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information